title: [Molecular targeting drugs].
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Ishikawa
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal; D015703:Antigens, CD / Q000276:immunology; D015195:Drug Design; D066246:ErbB Receptors / Q000276:immunology; D016044:Fusion Proteins, bcr-abl; D006801:Humans; D058990:Molecular Targeted Therapy; D046988:Proteasome Endopeptidase Complex; D011505:Protein-Tyrosine Kinases; D053245:RANK Ligand / Q000276:immunology; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology; D019947:Receptors, Interleukin-6 / Q000276:immunology; D015398:Signal Transduction; D058570:TOR Serine-Threonine Kinases; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology; D042461:Vascular Endothelial Growth Factor A / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D066246:ErbB Receptors; D016044:Fusion Proteins, bcr-abl; D046988:Proteasome Endopeptidase Complex; D011505:Protein-Tyrosine Kinases; D053245:RANK Ligand; D018719:Erb-b2 Receptor Tyrosine Kinases; D019947:Receptors, Interleukin-6; D058570:TOR Serine-Threonine Kinases; D014409:Tumor Necrosis Factor-alpha; D042461:Vascular Endothelial Growth Factor A; C512478:EGFR protein, human; C508053:ERBB2 protein, human